Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Authors
Keywords
Micelles, Targeted delivery, Triple negative breast cancer, Immunogenic cell death, Immunoadjuvant
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 341, Issue -, Pages 498-510
Publisher
Elsevier BV
Online
2021-12-07
DOI
10.1016/j.jconrel.2021.12.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation
- (2021) Yansen Xiao et al. CANCER CELL
- Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
- (2021) Elisa Agostinetto et al. Current Oncology Reports
- CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice
- (2020) Yinan Zhong et al. JOURNAL OF CONTROLLED RELEASE
- Multifunctional STING‐Activating Mn 3 O 4 @Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
- (2020) Min Zhou et al. Advanced Healthcare Materials
- Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy
- (2020) Yang Lan et al. ACS Applied Materials & Interfaces
- Pathology of triple negative breast cancer
- (2020) Filippo Borri et al. SEMINARS IN CANCER BIOLOGY
- The Age of Cyclic Dinucleotide Vaccine Adjuvants
- (2020) Himanshu Gogoi et al. Vaccines
- Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
- (2020) Wenxing Gu et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
- (2020) Jingjing Liang et al. Science Advances
- Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
- (2020) Leila Motedayen Aval et al. Journal of Clinical Medicine
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
- (2020) Gagan K. Gupta et al. Cancers
- Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
- (2020) Olivia K. Burn et al. Cancers
- Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
- (2019) Minhong Shen et al. CANCER CELL
- Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)8-paclitaxel prodrug: In Vivo conversion and antitumor efficacy
- (2019) Yu Tong Tam et al. JOURNAL OF CONTROLLED RELEASE
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
- (2019) Qiuhua Luo et al. CANCER LETTERS
- Progress in research on paclitaxel and tumor immunotherapy
- (2019) Linyan Zhu et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
- (2019) Yang Liu et al. Nature Communications
- Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma
- (2019) Yingwen Li et al. BIOMACROMOLECULES
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
- (2018) Jinyang Li et al. IMMUNITY
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Can innate immune system targets turn up the heat on 'cold' tumours?
- (2018) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Biodegradable, Drug-Loaded Nanovectors via Direct Hydration as a New Platform for Cancer Therapeutics
- (2018) Roxane Ridolfo et al. Small
- Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
- (2018) Michäel Duruisseaux et al. Lancet Respiratory Medicine
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Tumor microenvironment: Interactions and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
- (2018) Marcin Kowanetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paclitaxel nanoparticle awakens immune system to fight against cancer
- (2017) Wei Tang et al. Nanoscale
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin
- (2016) Hongren Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization
- (2014) Donna M. Veine et al. CLINICAL & EXPERIMENTAL METASTASIS
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system
- (2011) Sa-Won Lee et al. JOURNAL OF CONTROLLED RELEASE
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search